Acknowledgement
Thank all colleagues who helped with this research. Thank the editors and reviewers for their valuable comments on the paper.
References
- ACOG Practice Bulletin No. 204: Fetal Growth Restriction. 2019. Obstet. Gynecol. 133: e97-e109. https://doi.org/10.1097/AOG.0000000000003070
- Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP, Marcal VM, et al. 2017. Fetal growth restriction: current knowledge. Arch. Gynecol. Obstet. 295: 1061-1077. https://doi.org/10.1007/s00404-017-4341-9
- Srugo SA, Bloise E, Nguyen TTN, Connor KL. 2019. Impact of maternal malnutrition on gut barrier defense: implications for pregnancy health and fetal development. Nutrients 11: 1375.
- Connor KL, Kibschull M, Matysiak-Zablocki E, Nguyen TTN, Matthews SG, Lye SJ, et al. 2020. Maternal malnutrition impacts placental morphology and transporter expression: an origin for poor offspring growth. J. Nutr. Biochem. 78: 108329.
- Strandwitz P. 2018. Neurotransmitter modulation by the gut microbiota. Brain Res. 1693: 128-133. https://doi.org/10.1016/j.brainres.2018.03.015
- Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, et al. 2019.Gut microbiota and obesity: a role for probiotics. Nutrients 11: 2690.
- Fernandez-Gonzalez S, Ortiz-Arrabal O, Torrecillas A, Perez-Cruz M, Chueca N, Gomez-Roig MD, et al. 2020. Study of the fetal and maternal microbiota in pregnant women with intrauterine growth restriction and its relationship with inflammatory biomarkers: a case-control study protocol (SPIRIT compliant). Medicine 99: e22722.
- Palladino E, Van Mieghem T, Connor KL. 2021. Diet alters micronutrient pathways in the gut and placenta that regulate fetal growth and development in pregnant mice. Reprod. Sci. 28: 447-461. https://doi.org/10.1007/s43032-020-00297-1
- Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. 2016. Inflammation in complicated pregnancy and its outcome. Am. J. Perinatol. 33: 1337-1356. https://doi.org/10.1055/s-0036-1582397
- Nadeau-Vallee M, Obari D, Palacios J, Brien ME, Duval C, Chemtob S, et al. 2016. Sterile inflammation and pregnancy complications: a review. Reproduction 152: R277-R292. https://doi.org/10.1530/REP-16-0453
- Zong F, Zhao Y. 2021. Alkaloid leonurine exerts anti-inflammatory effects via modulating MST1 expression in trophoblast cells. Immun. Inflamm. Dis. 9: 1439-1446. https://doi.org/10.1002/iid3.493
- Baker BC, Heazell AEP, Sibley C, Wright R, Bischof H, Beards F, et al. 20201.Hypoxia and oxidative stress induce sterile placental inflammation in vitro. Sci. Rep. 11: 7281.
- Lee HH, Bae JM, Lee BI, Lee KM, Wie JH, Kim JS, et al. 2020. Pregnancy outcomes in women with inflammatory bowel disease: a 10- year nationwide population-based cohort study. Aliment. Pharmacol. Ther. 51: 861-869. https://doi.org/10.1111/apt.15654
- Fitzgerald KA, Kagan JC. 2020. Toll-like receptors and the control of immunity. Cell 180: 1044-1066. https://doi.org/10.1016/j.cell.2020.02.041
- Ciesielska A, Matyjek M, Kwiatkowska K. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell. Mol.Life Sci. 78: 1233-1261. https://doi.org/10.1007/s00018-020-03656-y
- Ryu JK, Kim SJ, Rah SH, Kang JI, Jung HE, Lee D, et al. 2017. Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer. Immunity 46: 38-50. https://doi.org/10.1016/j.immuni.2016.11.007
- Hong CP, Yun CH, Lee GW, Park A, Kim YM, Jang MH. 2015. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders. Obesity (Silver Spring). 23: 2199-2206. https://doi.org/10.1002/oby.21215
- Saikh KU. 2021. MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity. Immunol. Res. 69: 117-128. https://doi.org/10.1007/s12026-021-09188-2
- Afkham A, Eghbal-Fard S, Heydarlou H, Azizi R, Aghebati-Maleki L, Yousefi M. 2019. Toll-like receptors signaling network in preeclampsia: an updated review. J. Cell. Physiol. 234: 2229-2240. https://doi.org/10.1002/jcp.27189
- Liu H, Wang Y, Liu J, Fu W. 2019. Proteomics analysis of fetal growth restriction and taurinetreated fetal growth restriction rat brain tissue by 2D DIGE and MALDITOF/TOF MS analysis. Int. J. Mol. Med. 44: 207-217. https://doi.org/10.3892/ijmm.2019.4182
- X C, P Z, P L, G W, J L, Y W, et al. 2023. CpG ODN 1668 as TLR9 agonist mediates humpback grouper (Cromileptes altivelis) antibacterial immune responses. Fish Shellfish Immunol. 138: 108839.
- Zonneveld-Huijssoon E, van Wijk F, Roord S, Delemarre E, Meerding J, de Jager W, et al. 2012. TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis. Ann. Rheum. Dis. 71: 1706-1715. https://doi.org/10.1136/annrheumdis-2011-201131
- Damm J, Wiegand F, Harden LM, Wenisch S, Gerstberger R, Rummel C, et al. 2014. Intraperitoneal and subcutaneous injections of the TLR9 agonist ODN 1668 in rats: brain inflammatory responses are related to peripheral IL-6 rather than interferons. J. Neuroimmunol. 277: 105-117. https://doi.org/10.1016/j.jneuroim.2014.10.007
- Schrezenmeier E, Dorner T. 2020. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat. Rev. Rheumatol. 16: 155-166. https://doi.org/10.1038/s41584-020-0372-x
- Lamphier M, Zheng W, Latz E, Spyvee M, Hansen H, Rose J, et al. 2014. Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol. Pharmacol. 85: 429-440. https://doi.org/10.1124/mol.113.089821
- Gulden E, Chao C, Tai N, Pearson JA, Peng J, Majewska-Szczepanik M, et al. 2018. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells. J. Autoimmun. 93: 57-65. https://doi.org/10.1016/j.jaut.2018.06.003
- Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, et al. 1993 Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206: 204-211. https://doi.org/10.1006/excr.1993.1139
- Ueda H, Yamaguchi O, Taneike M, Akazawa Y, Wada-Kobayashi H, Sugihara R, et al. 2019. Administration of a TLR9 inhibitor attenuates the development and progression of heart failure in mice. JACC Basic Transl. Sci. 4: 348-363. https://doi.org/10.1016/j.jacbts.2019.01.002
- Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7: 335-336. https://doi.org/10.1038/nmeth.f.303
- Olmos-Ortiz A, Flores-Espinosa P, Mancilla-Herrera I, Vega-Sanchez R, Diaz L, Zaga-Clavellina V. 2019. Innate immune cells and toll-like receptor-dependent responses at the maternal-fetal interface. Int. J. Mol. Sci. 20: 3654.
- Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, James JL. 2020. The placenta in fetal growth restriction: what is going wrong? Placenta 96: 10-18. https://doi.org/10.1016/j.placenta.2020.05.003
- Shepard CR. 2020. TLR9 in MAFLD and NASH: at the intersection of inflammation and metabolism. Front. Endocrinol. (Lausanne). 11: 613639.
- Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. 2022. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct. Target. Ther. 7: 131.
- Abbas Y, Turco MY, Burton GJ, Moffett A. 2020. Investigation of human trophoblast invasion in vitro. Hum. Reprod. Update26: 501-513. https://doi.org/10.1093/humupd/dmaa017
- Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, et al. 2008. Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol. Hum. Reprod. 14: 547-554. https://doi.org/10.1093/molehr/gan046
- Yu L, Sun Y, Chu Z. 2021. MiR-212-3p promotes proliferation and migration of trophoblast in fetal growth restriction by targeting placental growth factor. Bioengineered 12: 5655-5663. https://doi.org/10.1080/21655979.2021.1967069
- Cui J, Kang X, Shan Y, Zhang M, Gao Y, Wu W, et al. 2022. miR-1227-3p participates in the development of fetal growth restriction via regulating trophoblast cell proliferation and apoptosis. Sci. Rep. 12: 6374.
- Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. 2021. Interaction between Lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int. J. Mol. Sci. 22: 6242.
- Mei C, Yang W, Wei X, Wu K, Huang D. 2019. The unique microbiome and innate immunity during pregnancy. Front. Immunol. 10: 2886.
- Cotechini T, Graham CH. 2015. Aberrant maternal inflammation as a cause of pregnancy complications: a potential therapeutic target? Placenta 36: 960-966. https://doi.org/10.1016/j.placenta.2015.05.016
- Leitner GR, Wenzel TJ, Marshall N, Gates EJ, Klegeris A. 2019. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. Expert Opin. Ther. Targets 23: 865-882. https://doi.org/10.1080/14728222.2019.1676416
- Zou Y, Huang Y, Liu S, Yang J, Zheng W, Deng Y, et al. 2022. Periodontopathic microbiota and Atherosclerosis: roles of TLR-mediated inflammation response. Oxid. Med. Cell Longev. 2022: 9611362.
- Cornish EF, Filipovic I, Asenius F, Williams DJ, McDonnell T. 2020. Innate immune responses to acute viral infection during pregnancy. Front. Immunol. 11: 572567.
- Aneman I, Pienaar D, Suvakov S, Simic TP, Garovic VD, McClements L. 2020. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front. Immunol. 11: 1864.
- Gao P, Ma X, Yuan M, Yi Y, Liu G, Wen M, et al. 2021. E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3. Nat. Commun. 12: 1194.
- Lin M, Ji X, Lv Y, Cui D, Xie J. 2023. The roles of TRAF3 in immune responses. Dis. Markers 2023: 7787803.
- Firmal P, Shah VK, Chattopadhyay S. 2020. Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Front. Immunol. 11: 807.
- Plociennikowska A, Hromada-Judycka A, Borzecka K, Kwiatkowska K. 2015. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol. Life Sci. 72: 557-581. https://doi.org/10.1007/s00018-014-1762-5
- Kalyan M, Tousif AH, Sonali S, Vichitra C, Sunanda T, Praveenraj SS, et al. 2022. Role of endogenous lipopolysaccharides in neurological disorders. Cells 11: 4038.
- Banoth B, Cassel SL. 2018. Mitochondria in innate immune signaling. Transl. Res. 202: 52-68. https://doi.org/10.1016/j.trsl.2018.07.014
- Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL, Jr., Darley-Usmar V, et al. 2022. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease. Acta Pharm. Sin. B. 12: 511-531. https://doi.org/10.1016/j.apsb.2021.06.014
- Kiyokoba R, Uchiumi T, Yagi M, Toshima T, Tsukahara S, Fujita Y, et al. 2022. Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restriction. Sci. Rep. 12: 4056.
- Msheik H, Azar J, El Sabeh M, Abou-Kheir W, Daoud G.2020. HTR-8/SVneo: a model for epithelial to mesenchymal transition in the human placenta. Placenta 90: 90-97. https://doi.org/10.1016/j.placenta.2019.12.013
- He B, Yang X, Li Y, Huang D, Xu X, Yang W, et al. 2018. 3 TLR9 (Toll-Like Receptor 9) agonist suppresses angiogenesis by differentially regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia. Hypertension 71: 671-680. https://doi.org/10.1161/HYPERTENSIONAHA.117.10510
- Williamson RD, McCarthy FP, Kenny LC, McCarthy CM. 2019. Activation of a TLR9 mediated innate immune response in preeclampsia. Sci. Rep. 9: 5920.
- Liu Q, Yang W, Luo N, Liu J, Wu Y, Ding J, et al. 2020. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. J. Cancer 11: 4413-4420. https://doi.org/10.7150/jca.41035
- Ravindran M, Khan MA, Palaniyar N. 2019. Neutrophil extracellular trap formation: physiology, pathology, and pharmacology. Biomolecules 9: 365.
- Mutua V, Gershwin LJ. 2021. A review of Neutrophil Extracellular Traps (NETs) in disease: potential anti-NETs therapeutics. Clin. Rev. Allergy Immunol. 61: 194-211. https://doi.org/10.1007/s12016-020-08804-7
- Beckers KF, Sones JL. 2020. Maternal microbiome and the hypertensive disorder of pregnancy, preeclampsia. Am. J. Physiol. Heart Circ. Physiol. 318: H1-H10. https://doi.org/10.1152/ajpheart.00469.2019
- Mustad VA, Huynh DTT, Lopez-Pedrosa JM, Campoy C, Rueda R. 2020. The role of dietary carbohydrates in gestational diabetes. Nutrients 12: 385.
- Lu Y, Li X, Liu S, Zhang Y, Zhang D. 2018. Toll-like receptors and inflammatory bowel disease. Front. Immunol. 9: 72.
- Massier L, Bluher M, Kovacs P, Chakaroun RM. 2021. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front. Endocrinol (Lausanne). 12: 616506.
- Wang X, Ni J, You Y, Feng G, Zhang S, Bao W, et al. 2021. SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade. EMBO J. 40: e108080.
- Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. 2021. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front. Immunol. 12: 578386.
- Tu X, Duan C, Lin B, Li K, Gao J, Yan H, et al. 2022. Characteristics of the gut microbiota in pregnant women with fetal growth restriction. BMC Pregnancy Childbirth 22: 297.
- Ding P, Tan Q, Wei Z, Chen Q, Wang C, Qi L, et al. 2022. Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation. Bone Res. 10: 42.
- Martinez-Colon G, Warheit-Niemi H, Gurczynski S, Taylor Q, Wilke C, Podsiad A, et al. 2019. Influenza-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9. PLoS Pathog. 15: e1007560.
- Charlet R, Bortolus C, Sendid B, Jawhara S. 2020. Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall. Sci. Rep. 10: 11510.
- Huang J, Tan Q, Tai N, Pearson JA, Li Y, Chao C, et al. 2021. IL-10 deficiency accelerates type 1 diabetes development via modulation of innate and adaptive immune cells and gut microbiota in BDC2.5 NOD mice. Front. Immunol. 12: 702955.
- Zhang W, Zou G, Li B, Du X, Sun Z, Sun Y, et al. 2020. Fecal Microbiota Transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation. J. Microbiol. Biotechnol. 30: 1132-1141. https://doi.org/10.4014/jmb.2002.02044
- Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, et al. 2020. Fecal microbiota transplantation in neurological disorders. Front. Cell Infect. Microbiol. 10: 98.
- Chen D, Wu J, Jin D, Wang B, Cao H. 2019. Fecal microbiota transplantation in cancer management: current status and perspectives. Int. J. Cancer 145: 2021-2031. https://doi.org/10.1002/ijc.32003
- Huang C, Wu D, Zhang K, Khan FA, Pandupuspitasari NS, Wang Y, et al. 2022. Perfluorooctanoic acid alters the developmental trajectory of female germ cells and embryos in rodents and its potential mechanism. Ecotoxicol. Environ. Saf. 236: 113467.